BioInformant

Your Global Leader in Stem Cell Market Research

MENUMENU
  • Blog
    • Interviews
  • News
  • Stem Cells
    • iPS Cells
    • MSCs
    • HSCs
    • Adipose SCs
    • Neural Stem Cells
  • Exosomes
  • CAR-T
  • Cord Blood
  • Shop
    • Products
    • Submit PR
    • Advertise
  • About
    • Testimonials
    • Story
    • Guarantee
    • Contact
  • Home
  • Blog
    • Stem Cells
      • HSCs
      • iPS Cells
      • MSCs
      • Neural Stem Cells
      • Adipose SCs
    • Exosomes
    • Cell Therapy
      • CAR-T
    • Cord Blood
    • Stem Cell News
    • Interviews
  • COVID-19
  • Shop
  • Submit PR
  • Company
    • Advertise
    • Testimonials
    • Story
    • Job Posts
    • Guarantee
    • Privacy Policy
    • Contact
Home » Stem Cells » Page 167

Induced Pluripotent Stem Cell News Round-Up | July 2015

August 12, 2015 By Cade Hildreth (CEO) Leave a Comment

Induced pluripotent stem cells (iPSCs) represent a rapidly evolving area of stem cell science. Since the discovery of the cell type in 2006, there have been several important market events, including the first ever clinical trial in humans which launched in August of 2013 to evaluate the capacity of iPSC-derived cell sheets for their ability to restore vision in patients with wet-type macular degeneration. While this trial has since been paused due to safety concerns, it represents a major milestone in clinical progress with iPSCs.

In another recent event that reverberated throughout the stem cell research community, the Supreme Court rejected the right of the Wisconsin Alumni Research Foundation (WARF) to control patents related to iPSC derivation in a landmark patent decision issued February 2015.

Indeed, every month there are major events occurring in the iPSC sector that shift industry dynamics. Read on to get informed about the most important iPSC market events that occurred in July of 2015.  [Read more…]

Filed Under: iPS Cells, Stem Cells Tagged With: current events, induced pluripotent stem cell, industry news, iPS cells, iPSC, iPSC market, news round up

Price-per-Click Costs Reveal Current Levels of Market Competition for iPS Cells

July 22, 2015 By Cade Hildreth (CEO) Leave a Comment

Price-per-Click Costs Reveal Current Levels of Market Competition for iPSCs

Purpose of Induced Pluripotent Stem Cell (iPSC) Marketing Analysis

An important area to consider for purposes of quantifying and assessing conditions within the iPSC market is marketing costs.

 Because Google now controls over 70% of online searches, Google Adwords is the single best resource available for analyzing both marketing costs and online search behavior within the induced pluripotent stem cell (iPSC) market.  Specifically, this post considers marketing costs for search terms related to iPSCs, using the Google Adwords tool.
[Read more…]

Filed Under: iPS Cells, Stem Cells Tagged With: induced pluripotent stem cells, iPS cells, iPS cells industry, market analysis, market competition, price per click

Epic Year for Regenerative Medicine Investments

July 17, 2015 By Cade Hildreth (CEO) Leave a Comment

EPIC YEAR FOR REGENERATIVE MEDICINE INVESTMENTS

In the past twelve months, regenerative medicine investments gained momentum, as new and promising clinical data got released. The momentum has been growing in recent years, enabling the cell therapy and genome editing sectors to evolve into a global industry.

[Read more…]

Filed Under: Adipose SCs, HSCs, iPS Cells, MSCs, Neural Stem Cells, Stem Cells Tagged With: financial events, Juno Therapeutics, mesenchymal stem cells, regenerative medicine, regenerative medicine industry

Mesenchymal Stem Cell Industry News Round Up | July 2015

July 16, 2015 By Cade Hildreth (CEO) Leave a Comment

Mesenchymal Stem Cell Industry News July 2015 Round-Up

The mesenchymal stem cell industry is well-known for its shifting dynamics, including new alliances, new research advances and innovations. Every month there are major new events that affect market participants.

While it may be possible to stay informed about mesenchymal stem cell industry news in your region, it can be more difficult to track changes on a global scale. For that reason, the following is a summary of significant mesenchymal stem cell industry events for July 2015.

[Read more…]

Filed Under: MSCs, Stem Cells Tagged With: current events, IL-17, industry news, mesenchymal stem cells, Mesoblast Limited, MiMedx, systematic lupus erythematosus

July is National Cord Blood Awareness Month

July 15, 2015 By Cade Hildreth (CEO) Leave a Comment

July National Cord Blood Month

July is National Cord Blood Awareness Month. It is a time during which the importance of cord blood and tissue stem cells is celebrated. Importantly, hematopoietic stem cells (HSCs) from cord blood can now be used to treat more than 80 diseases and conditions. Mesenchymal stem cells present in cord tissue are also being explored in a wide range of clinical trials.

Cord Blood Awareness

There are three primary categories of people who need to increase their awareness about the importance of cord blood stem cells. These categories include:

  1. Expectant (pregnant) parents
  2. Extended support networks for parents, including brothers, sisters, grandparents, aunts, uncles and friends
  3. Medical practitioners, including nurses and Ob/Gyns

[Read more…]

Filed Under: Cord Blood, HSCs, MSCs Tagged With: cord blood

  • « Previous Page
  • 1
  • …
  • 165
  • 166
  • 167
  • 168
  • 169
  • …
  • 178
  • Next Page »

Nanocellect

Marathon Products

Kimera Society

Let’s Get Social

  • Facebook
  • Twitter
  • LinkedIn
  • Pinterest
  • Instagram

Cart

Top Rated Products

  • Job Posting on BioInformant <Job Posting on BioInformant.com - Your Perfect Hire Is In Our Audience $297
  • U.S. Cord Blood Banking Survey <Cord Blood Banking Survey of U.S. Parents [2017] $197
  • Exosome Companies 2020 <Global Database of Exosome Companies $149 $97

Featured Posts

Who discovered stem cells?

Who Discovered Stem Cells? The Answers Revealed

iPSC derived cell therapeutics

The Pipeline for iPSC-Derived Cell Therapeutics in 2022

Stem cell companies

List of Stem Cell Companies Worldwide (2022)

My Tweets

BioInformant's World-Class Clients

  • Submit Press Release
  • Advertise
  • Privacy and Terms

Copyright © 2022 · BIOINFORMANT, Your Global Leader in Stem Cell Market Research

| Email: [email protected] | Phone: 703-859-7617 |

800 Corporate Drive, Suite 301, Stafford, VA 22554, United States

Disclaimer: All statements made on this website are NOT expressed as medical claims or advice. They are not intended to diagnose, treat, cure or prevent any disease or condition. If you have a health condition or concern, consult your physician or health care provider.